183 related articles for article (PubMed ID: 25093381)
21. Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia.
Vatel O; Aumont C; Mathy V; Petit M; Feriel J; Sloma I; Bennaceur-Griscelli A; Turhan AG
Leuk Lymphoma; 2017 Feb; 58(2):473-474. PubMed ID: 27389710
[No Abstract] [Full Text] [Related]
22. Myelodysplastic syndrome (MDS)-associated cytogenetic abnormalities in pediatric chronic myelogenous leukemia.
Kumar KR; Koduru P; Timmons C; Monaghan S; Cavalier M; Luu HS
Pediatr Blood Cancer; 2013 Nov; 60(11):E146-8. PubMed ID: 23868765
[TBL] [Abstract][Full Text] [Related]
23. Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones.
Chee YL; Vickers MA; Stevenson D; Holyoake TL; Culligan DJ
Leukemia; 2003 Mar; 17(3):634-5. PubMed ID: 12646955
[No Abstract] [Full Text] [Related]
24. Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib.
Pieńkowska-Grela B; Rygier J; Woroniecka R; Grygalewicz B; Pastwińska A; Krawczyk P; Ceglerek B; Seferyńska I; Sikorska A; Konopka L
Leuk Lymphoma; 2009 Jun; 50(6):952-65. PubMed ID: 19479611
[TBL] [Abstract][Full Text] [Related]
25. Imatinib mesylate- and dasatinib-induced eosinophilia in a patient with chronic myelocytic leukemia.
McGrath K; Stein B; Kalhagen L; Leighton L
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):85-86. PubMed ID: 28499700
[No Abstract] [Full Text] [Related]
26. Sequential chronic myelogenous leukemia, B-lineage lymphoma and erythroleukemia with monosomy 7 over 10 years.
Au WY; Wan TS; Leung RY; Lie AK
Leuk Lymphoma; 2012 Apr; 53(4):733-5. PubMed ID: 21958131
[No Abstract] [Full Text] [Related]
27. Double minute chromosomes and monosomy 7 in a lymphatic blast crisis of chronic myeloid leukemia.
Cigudosa JC; Calasanz MJ; Gullon A; Ezpeleta I; Oyarzabal FJ
Cancer Genet Cytogenet; 1990 Aug; 48(1):133-4. PubMed ID: 2372781
[No Abstract] [Full Text] [Related]
28. Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case.
Mozziconacci MJ; Caillères S; Maurice C; Vey N; Sainty D; Blaise D; Lafage-Pochitaloff M
Leukemia; 2003 Sep; 17(9):1901-2. PubMed ID: 12970792
[No Abstract] [Full Text] [Related]
29. Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.
Cortes J; Talpaz M; O'Brien S; Jones D; Luthra R; Shan J; Giles F; Faderl S; Verstovsek S; Garcia-Manero G; Rios MB; Kantarjian H
Clin Cancer Res; 2005 May; 11(9):3425-32. PubMed ID: 15867244
[TBL] [Abstract][Full Text] [Related]
30. Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease.
Kneller A; Cohen N; Berkowicz M; Reichart M; Rosner E; Sokolovski M; Nagler A; Rechavi G; Amariglio N; Trakhtenbrot L
Cancer Genet Cytogenet; 2005 May; 159(1):58-62. PubMed ID: 15860359
[TBL] [Abstract][Full Text] [Related]
31. Fluorescence in situ hybridization analysis of minimal residual disease and the relevance of the der(9) deletion in imatinib-treated patients with chronic myeloid leukemia.
Calabrese G; Fantasia D; Di Gianfilippo R; Stuppia L; Di Lorenzo R; Palka G
Haematologica; 2006 Jul; 91(7):994-5. PubMed ID: 16818290
[TBL] [Abstract][Full Text] [Related]
32. Imatinib-Associated Pneumocystis jirovecii Pneumonia in a Patient With Chronic Myeloid Leukemia.
Daw J; Thapa B; Chahine J; Lak H; Perez O; Nair R; Alomari M; Haddad A
Am J Ther; 2020; 27(4):e406-e409. PubMed ID: 31356343
[No Abstract] [Full Text] [Related]
33. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
Terre C; Eclache V; Rousselot P; Imbert M; Charrin C; Gervais C; Mozziconacci MJ; Maarek O; Mossafa H; Auger N; Dastugue N; Talmant P; Van den Akker J; Leonard C; N'Guyen Khac F; Mugneret F; Viguié F; Lafage-Pochitaloff M; Bastie JN; Roux GL; Nicolini F; Maloisel F; Vey N; Laurent G; Recher C; Vigier M; Yacouben Y; Giraudier S; Vernant JP; Salles B; Roussi J; Castaigne S; Leymarie V; Flandrin G; Lessard M;
Leukemia; 2004 Aug; 18(8):1340-6. PubMed ID: 15190256
[TBL] [Abstract][Full Text] [Related]
34. Imatinib-induced pyoderma gangrenosum in a patient with chronic myeloid leukemia.
Faraci AG; Genovese G; Ferrucci S; Marzano AV
Indian J Dermatol Venereol Leprol; 2021; 87(5):704-706. PubMed ID: 34114414
[No Abstract] [Full Text] [Related]
35. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
36. Lytic bone disease as the presenting feature of Philadelphia-positive monosomy 7 myelodysplasia progressing to acute myeloid leukaemia.
Tucker D; Hamilton MS; Kerr JP; Wickham C; Hunter H
Gene; 2012 Jun; 501(2):219-21. PubMed ID: 22537673
[TBL] [Abstract][Full Text] [Related]
37. Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
Hackanson B; Rückert A; Lübbert M
Eur J Haematol; 2009 Dec; 83(6):611-2. PubMed ID: 19682063
[No Abstract] [Full Text] [Related]
38. Imatinib-induced pseudoporphyria.
Martinez-Mera C; Capusan TM; Herrero-Moyano M; Urquía Renke A; Steegmann Olmedillas JL; de Argila D
Clin Exp Dermatol; 2018 Jun; 43(4):463-466. PubMed ID: 29315788
[No Abstract] [Full Text] [Related]
39. Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia.
Scott AD; Lee M; Kubba F; Chu A
Clin Exp Dermatol; 2015 Dec; 40(8):926-7. PubMed ID: 25266712
[No Abstract] [Full Text] [Related]
40. Second primary malignancies in chronic myeloid leukemia patients.
Caliskan T; Eskazan AE
J Cancer Res Ther; 2015; 11(4):1042. PubMed ID: 26881669
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
